Carregant...
Advances in Sickle Cell Therapies in the Hydroxyurea Era
In the hydroxyurea era, insights into mechanisms downstream of erythrocyte sickling have led to new therapeutic approaches for patients with sickle cell disease (SCD). Therapies have been developed that target vascular adhesion, inflammation and hemolysis, including innovative biologics directed aga...
Guardat en:
| Publicat a: | Mol Med |
|---|---|
| Autors principals: | , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
ScholarOne
2014
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4374518/ https://ncbi.nlm.nih.gov/pubmed/25549232 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2119/molmed.2014.00187 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|